Clinical Trials Browser

Cholangiocarcinoma × olaparib × CNS × Clear all

NCT03212274 2026-02-19

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Phase 2 Active not recruiting

CNSGastrointestinal

Glioblastoma, Glioma, Cholangiocarcinoma

NCT03991832 2024-07-18

SOLID

Phase 2 Recruiting

CNSGastrointestinal

Glioma, Cholangiocarcinoma